Antibody engineering techniques permit the exploitation of the highly
specific and diverse nature of the humoral immune system. Intracellula
r antibodies, consisting minimally of the antigen-binding domains of t
he patent immunoglobulin protein, may be used to manipulate microbial
and cellular target molecules. Applications of this technology describ
ed to date include inhibition of replication of an infectious virus, d
ownregulation of growth factor receptors, and inactivation of oncoprot
eins in cell culture systems. The ability to functionally manipulate v
irtually any target molecule using intracellular antibodies is clearly
beneficial to basic science and molecular medicine.